“We should have been developing this ourselves, Chris. And you talked about this early on, there was a strategic, I think, method to minimizing this by not testing,” Gupta claimed. “Sad to say, but I think that’s the truth now, you sort of suggested that early on and I thought, maybe we’re just behind. But I think it was deliberate now at this point to not test, because it would make things look bad, we should have had significant breakthroughs in antigen testing by now.”